Viw Magazine

Men's Weekly

.

We don't need to change how we subsidise 'breakthrough' cancer treatments

  • Written by Richard De Abreu Lourenco, Senior Research Fellow, University of Technology Sydney
imageApplications to list drugs on the PBS are usually submitted by the manufacturers of those drugs.from shutterstock.com

New therapies that arm the immune system to fight cancer, such as Keytruda (pembrolizumab) and Yervoy (ipilimumab), have offered patients with advanced melanoma real hope of effective treatment.

But until these drugs, known as...

Read more

LifeStyle

Why Hurstville Tutoring Supports Strong Academic Growth And Confidence

Students in academically competitive areas often face increasing pressure to perform well across m...

Is a Pop Top Caravan Suitable for a Family of Four?

For families planning road trips across Australia, choosing the right caravan layout can shape the...

The Structural Foundation of Secure and Refined Entrances: Gate Hardware

A gate often forms the first point of contact between a property and the outside world. Its presen...

Considering Combined Surgical Approaches for Natural-Looking Results

Cosmetic procedures are no longer viewed as single, isolated treatments. Many individuals explorin...